{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:30:17Z","timestamp":1790281817007,"version":"4.1.0"},"reference-count":87,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1097\/nrl.0b013e3181ebe59f","type":"journal-article","created":{"date-parts":[[2010,9,8]],"date-time":"2010-09-08T07:15:37Z","timestamp":1283930137000},"page":"287-297","source":"Crossref","is-referenced-by-count":99,"title":["Peripheral Nervous System Manifestations of Sj\u00f6gren Syndrome"],"prefix":"10.1097","volume":"16","author":[{"given":"Julius","family":"Birnbaum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210211","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","article-title":"Sj\u00f6gren's syndrome.","volume":"366","author":"Fox","year":"2005","journal-title":"Lancet"},{"key":"R2-2-20210211","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/03009740310004676","article-title":"Estimating the prevalence among Caucasian women of primary Sj\u00f6gren's syndrome in two general practices in Birmingham, UK.","volume":"33","author":"Bowman","year":"2004","journal-title":"Scand J Rheumatol"},{"key":"R3-2-20210211","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.rdc.2008.08.004","article-title":"New concepts in the pathogenesis of Sj\u00f6gren's syndrome.","volume":"34","author":"Delaleu","year":"2008","journal-title":"Rheum Dis Clin North Am"},{"key":"R4-2-20210211","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.arcmed.2006.08.002","article-title":"Pathophysiology of Sj\u00f6gren's syndrome.","volume":"37","author":"Garcia-Carrasco","year":"2006","journal-title":"Arch Med Res"},{"key":"R5-2-20210211","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.rdc.2008.08.001","article-title":"Involvement of nervous system pathways in primary Sj\u00f6gren's syndrome.","volume":"34","author":"Segal","year":"2008","journal-title":"Rheum Dis Clin North Am"},{"key":"R6-2-20210211","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0188-4409(01)00371-X","article-title":"The oral side of Sjogren syndrome. Diagnosis and treatment. A review.","volume":"33","author":"Soto-Rojas","year":"2002","journal-title":"Arch Med Res"},{"key":"R7-2-20210211","first-page":"6","article-title":"Evaluation, differential diagnosis, and treatment of xerostomia.","volume":"61","author":"Daniels","year":"2000","journal-title":"J Rheumatol Suppl"},{"key":"R8-2-20210211","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"R9-2-20210211","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0889-857X(21)00317-3","article-title":"Salivary and oral components of Sj\u00f6gren's syndrome.","volume":"18","author":"Daniels","year":"1992","journal-title":"Rheum Dis Clin North Am"},{"key":"R11-2-20210211","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0049-0172(98)80040-1","article-title":"Predictors of lymphoma development in primary Sj\u00f6gren's syndrome.","volume":"28","author":"Sutcliffe","year":"1998","journal-title":"Semin Arthritis Rheum"},{"key":"R12-2-20210211","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0049-0172(00)80016-5","article-title":"Clinical evolution, and morbidity and mortality of primary Sj\u00f6gren's syndrome.","volume":"29","author":"Skopouli","year":"2000","journal-title":"Semin Arthritis Rheum"},{"key":"R13-2-20210211","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/rheumatology\/38.3.245","article-title":"Primary Sj\u00f6gren's syndrome in the North East of England: a long-term follow-up study.","volume":"38","author":"Davidson","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"R14-2-20210211","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1136\/ard.2008.098301","article-title":"Neuropsychiatric syndromes in patients with systemic lupus erythematosus and primary Sjogren syndrome: a comparative population-based study.","volume":"68","author":"Harboe","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R15-2-20210211","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/rheumatology\/29.1.21","article-title":"The spectrum of neurological involvement in Sj\u00f6gren's syndrome.","volume":"29","author":"Andonopoulos","year":"1990","journal-title":"Br J Rheumatol"},{"key":"R16-2-20210211","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s100670050105","article-title":"Neurological involvement in primary Sj\u00f6gren's syndrome: clinical and instrumental evaluation in a cohort of Italian patients.","volume":"18","author":"Govoni","year":"1999","journal-title":"Clin Rheumatol"},{"key":"R17-2-20210211","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1212\/WNL.43.12.2574","article-title":"Antineuronal antibodies in patients with neurologic complications of primary Sj\u00f6gren's syndrome.","volume":"43","author":"Moll","year":"1993","journal-title":"Neurology"},{"key":"R18-2-20210211","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1600-0404.1990.tb00951.x","article-title":"Nervous system manifestations in Sj\u00f6gren's syndrome.","volume":"81","author":"Hietaharju","year":"1990","journal-title":"Acta Neurol Scand"},{"key":"R19-2-20210211","doi-asserted-by":"crossref","first-page":"751","DOI":"10.7326\/0003-4819-70-4-751","article-title":"The neuropathy of Sj\u00f6gren's syndrome. Trigeminal nerve involvement.","volume":"70","author":"Kaltreider","year":"1969","journal-title":"Ann Intern Med"},{"key":"R20-2-20210211","first-page":"207","article-title":"Neuropsychiatric abnormalities in primary Sj\u00f6gren's syndrome.","volume":"7","author":"Drosos","year":"1989","journal-title":"Clin Exp Rheumatol"},{"key":"R21-2-20210211","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0002-9343(86)90044-6","article-title":"Primary Sj\u00f6gren's syndrome in men. Clinical, serologic, and immunogenetic features.","volume":"80","author":"Molina","year":"1986","journal-title":"Am J Med"},{"key":"R22-2-20210211","first-page":"185","article-title":"Clinical, serological, and HLA phenotype subsets in Sj\u00f6gren's syndrome.","volume":"7","author":"Pease","year":"1989","journal-title":"Clin Exp Rheumatol"},{"key":"R23-2-20210211","doi-asserted-by":"crossref","first-page":"185","DOI":"10.7326\/0003-4819-91-2-185","article-title":"Autoantibodies and the spectrum of Sj\u00f6gren's syndrome.","volume":"91","author":"Martinez-Lavin","year":"1979","journal-title":"Ann Intern Med"},{"key":"R24-2-20210211","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1600-0404.1994.tb01629.x","article-title":"Neurological and neuropsychiatric dysfunction in primary Sj\u00f6gren's syndrome.","volume":"89","author":"Mauch","year":"1994","journal-title":"Acta Neurol Scand"},{"key":"R25-2-20210211","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MD.0b013e318181e6af","article-title":"Primary Sjogren syndrome in Spain: clinical and immunologic expression in 1010 patients.","volume":"87","author":"Ramos-Casals","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"R26-2-20210211","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/jnnp.60.6.699","article-title":"Intravenous immunoglobulin therapy in sensory neuropathy associated with Sj\u00f6gren's syndrome.","volume":"60","author":"Molina","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"suppl 10","key":"R27-2-20210211","first-page":"506","article-title":"Peripheral neuropathy is an uncommon cause of neuropathic symptoms in Sj\u00f6gren's patients.","volume":"60","author":"Birnbaum","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"suppl","key":"R28-2-20210211","first-page":"S448","article-title":"Prevalence of sensory symptoms in primary Sj\u00f6gren's syndrome (PSS) and relationship of neuropathic symptoms to depression and fibromyalgia.","volume":"56","author":"Segal","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R29-2-20210211","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/mus.20100","article-title":"Clinical features and pathophysiological basis of sensory neuronopathies (ganglionopathies).","volume":"30","author":"Kuntzer","year":"2004","journal-title":"Muscle Nerve"},{"key":"R30-2-20210211","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00019052-199710000-00002","article-title":"Autoimmune ataxic neuropathies (sensory ganglionopathies).","volume":"10","author":"O'Leary","year":"1997","journal-title":"Curr Opin Neurol"},{"key":"R31-2-20210211","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1001\/archneur.1994.00540230041010","article-title":"Pseudochoreoathetosis. Movements associated with loss of proprioception.","volume":"51","author":"Sharp","year":"1994","journal-title":"Arch Neurol"},{"key":"R32-2-20210211","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1093\/brain\/awh605","article-title":"The wide spectrum of clinical manifestations in Sj\u00f6gren's syndrome-associated neuropathy.","volume":"128","author":"Mori","year":"2005","journal-title":"Brain"},{"key":"R33-2-20210211","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1212\/WNL.48.4.855","article-title":"Peripheral neuropathy associated with sicca complex.","volume":"48","author":"Grant","year":"1997","journal-title":"Neurology"},{"key":"R34-2-20210211","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0035-3787(06)75144-X","article-title":"Ganglionopathies: evolving concept and ideas on management.","volume":"162","author":"Kuntzer","year":"2006","journal-title":"Rev Neurol (Paris)"},{"key":"R35-2-20210211","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/jnnp.71.4.488","article-title":"Spinal cord magnetic resonance imaging demonstrates sensory neuronal involvement and clinical severity in neuronopathy associated with Sj\u00f6gren's syndrome.","volume":"71","author":"Mori","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R36-2-20210211","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1212\/WNL.51.2.650-b","article-title":"High-dose i. v. immunoglobulin for peripheral neuropathy associated with Sj\u00f6gren's syndrome.","volume":"51","author":"Pascual","year":"1998","journal-title":"Neurology"},{"key":"R37-2-20210211","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1093\/brain\/awh662","article-title":"The clinical heterogeneity of immune sensory and autonomic neuropathies with (or without) sicca.","volume":"128","author":"Dyck","year":"2005","journal-title":"Brain"},{"key":"R38-2-20210211","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1212\/01.WNL.0000046680.47883.7D","article-title":"Benefit of IVIG for long-standing ataxic sensory neuronopathy with Sj\u00f6gren's syndrome. IV immunoglobulin.","volume":"60","author":"Takahashi","year":"2003","journal-title":"Neurology"},{"key":"R39-2-20210211","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1017\/S0317167100006697","article-title":"Primary Sj\u00f6gren's syndrome associated neuropathy.","volume":"34","author":"Mellgren","year":"2007","journal-title":"Can J Neurol Sci"},{"key":"R40-2-20210211","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.410270313","article-title":"Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sj\u00f6gren's syndrome.","volume":"27","author":"Griffin","year":"1990","journal-title":"Ann Neurol"},{"key":"R41-2-20210211","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ana.410200416","article-title":"Subacute sensory neuronopathy secondary to dorsal root ganglionitis in primary Sj\u00f6gren's syndrome.","volume":"20","author":"Malinow","year":"1986","journal-title":"Ann Neurol"},{"key":"R42-2-20210211","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1091\/mbc.01-11-0544","article-title":"A phosphorylated cytoplasmic autoantigen, GW182, associates with a unique population of human mRNAs within novel cytoplasmic speckles.","volume":"13","author":"Eystathioy","year":"2002","journal-title":"Mol Biol Cell"},{"key":"R43-2-20210211","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clim.2007.07.016","article-title":"Clinical and serological features of patients with autoantibodies to GW\/P bodies.","volume":"125","author":"Bhanji","year":"2007","journal-title":"Clin Immunol"},{"key":"R44-2-20210211","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mus.20514","article-title":"Peripheral neuropathy in an outpatient cohort of patients with Sj\u00f6gren's syndrome.","volume":"33","author":"Lopate","year":"2006","journal-title":"Muscle Nerve"},{"key":"R45-2-20210211","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/archneur.63.11.1612","article-title":"Peripheral neuropathy in primary Sjogren syndrome: a population-based study.","volume":"63","author":"Goransson","year":"2006","journal-title":"Arch Neurol"},{"key":"R46-2-20210211","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/mus.10181","article-title":"Small-fiber neuropathy.","volume":"26","author":"Lacomis","year":"2002","journal-title":"Muscle Nerve"},{"key":"R47-2-20210211","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/00131402-200006000-00008","article-title":"Use of skin biopsy and skin blister in neurologic practice.","volume":"1","author":"Kennedy","year":"2000","journal-title":"J Clin Neuromuscul Dis"},{"key":"R48-2-20210211","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ana.410440111","article-title":"Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases.","volume":"44","author":"Holland","year":"1998","journal-title":"Ann Neurol"},{"key":"R49-2-20210211","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1212\/WNL.56.7.861","article-title":"Autonomic impairment in painful neuropathy.","volume":"56","author":"Novak","year":"2001","journal-title":"Neurology"},{"key":"R50-2-20210211","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1212\/WNL.53.8.1641","article-title":"Painful sensory neuropathy: prospective evaluation using skin biopsy.","volume":"53","author":"Periquet","year":"1999","journal-title":"Neurology"},{"key":"R51-2-20210211","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1212\/01.wnl.0000176034.38198.f9","article-title":"Painful small-fiber neuropathy in Sjogren syndrome.","volume":"65","author":"Chai","year":"2005","journal-title":"Neurology"},{"key":"R52-2-20210211","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3949\/ccjm.76a.08070","article-title":"Small fiber neuropathy: a burning problem.","volume":"76","author":"Tavee","year":"2009","journal-title":"Cleve Clin J Med"},{"key":"R53-2-20210211","doi-asserted-by":"crossref","first-page":"b3002","DOI":"10.1136\/bmj.b3002","article-title":"Diagnosis and management of neuropathic pain.","volume":"339","author":"Freynhagen","year":"2009","journal-title":"BMJ"},{"key":"R54-2-20210211","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00019053-200927020-00002","article-title":"Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy.","volume":"27","author":"O'Connor","year":"2009","journal-title":"Pharmacoeconomics"},{"key":"R55-2-20210211","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1155\/2007\/730785","article-title":"Pharmacological management of chronic neuropathic pain\u2014consensus statement and guidelines from the Canadian Pain Society.","volume":"12","author":"Moulin","year":"2007","journal-title":"Pain Res Manag"},{"key":"R56-2-20210211","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1468-1331.2006.01511.x","article-title":"EFNS guidelines on pharmacological treatment of neuropathic pain.","volume":"13","author":"Attal","year":"2006","journal-title":"Eur J Neurol"},{"key":"R57-2-20210211","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","article-title":"Pharmacologic management of neuropathic pain: evidence-based recommendations.","volume":"132","author":"Dworkin","year":"2007","journal-title":"Pain"},{"key":"R58-2-20210211","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.clpt.2003.09.019","article-title":"Cyclic antidepressants and the risk of sudden cardiac death.","volume":"75","author":"Ray","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"R59-2-20210211","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4158\/EP.15.3.203","article-title":"Correlation of symptoms with vitamin D deficiency and symptom response to cholecalciferol treatment: a randomized controlled trial.","volume":"15","author":"Arvold","year":"2009","journal-title":"Endocr Pract"},{"key":"R60-2-20210211","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3109\/s10165-009-0180-2","article-title":"Extreme efficacy of intravenous immunoglobulin therapy for severe burning pain in a patient with small fiber neuropathy associated with primary Sj\u00f6gren's syndrome.","volume":"19","author":"Wakasugi","year":"2009","journal-title":"Mod Rheumatol"},{"key":"R61-2-20210211","first-page":"279","article-title":"Intravenous immunoglobulin treatment for painful sensory neuropathy associated with Sj\u00f6gren's syndrome.","volume":"15","author":"Morozumi","year":"2009","journal-title":"J Neurol Sci"},{"key":"R62-2-20210211","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/01.md.0000141099.53742.16","article-title":"Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients.","volume":"83","author":"Delalande","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"R63-2-20210211","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/01.nrl.0000252942.14928.17","article-title":"Vasculitic neuropathies: an update.","volume":"13","author":"Gorson","year":"2007","journal-title":"Neurologist"},{"key":"R64-2-20210211","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00415-005-0833-9","article-title":"Primary and secondary vasculitic neuropathy.","volume":"252","author":"Said","year":"2005","journal-title":"J Neurol"},{"key":"R65-2-20210211","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.rdc.2007.09.002","article-title":"Vasculitis: a collection of pearls and myths.","volume":"33","author":"Stone","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"key":"R66-2-20210211","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/archneurol.2009.76","article-title":"Primary angiitis of the central nervous system.","volume":"66","author":"Birnbaum","year":"2009","journal-title":"Arch Neurol"},{"key":"R67-2-20210211","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/ncprheum0139","article-title":"Therapeutics of Wegener's granulomatosis.","volume":"2","author":"Wung","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"R68-2-20210211","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/art.23102","article-title":"Diagnostic and prognostic relevance of neuromuscular biopsy in primary Sj\u00f6gren's syndrome-related neuropathy.","volume":"57","author":"Terrier","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R69-2-20210211","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/ki.2009.247","article-title":"Hepatitis C virus-induced cryoglobulinemia.","volume":"76","author":"Charles","year":"2009","journal-title":"Kidney Int"},{"key":"R70-2-20210211","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/MD.0b013e3181b76ab5","article-title":"Hematologic manifestations and predictors of lymphoma development in primary Sjogren syndrome: clinical and pathophysiologic aspects.","volume":"88","author":"Baimpa","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"R71-2-20210211","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jns.2008.08.001","article-title":"A rare cause of reversible unilateral third nerve palsy.","volume":"275","author":"Lui","year":"2008","journal-title":"J Neurol Sci"},{"key":"R72-2-20210211","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0022-510X(00)00344-0","article-title":"Trochlear nerve palsy in Sj\u00f6gren's syndrome.","volume":"177","author":"Chu","year":"2000","journal-title":"J Neurol Sci"},{"key":"R73-2-20210211","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/mus.21274","article-title":"Subacute inflammatory polyradiculopathy associated with Sj\u00f6gren's syndrome.","volume":"39","author":"Rigamonti","year":"2009","journal-title":"Muscle Nerve"},{"key":"R74-2-20210211","first-page":"481","article-title":"3 cases of rare peripheral neuropathies associated with primary Gougerot-Sjogren syndrome.","volume":"149","author":"Pou Serradell","year":"1993","journal-title":"Rev Neurol (Paris)"},{"key":"R75-2-20210211","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1468-1331.2004.00846.x","article-title":"Primary Sj\u00f6gren's syndrome presenting with generalized autonomic failure.","volume":"11","author":"Sakakibara","year":"2004","journal-title":"Eur J Neurol"},{"key":"R76-2-20210211","first-page":"296","article-title":"Sympathetic dysfunction in patients with primary Sj\u00f6gren's syndrome.","volume":"28","author":"Mandl","year":"2001","journal-title":"J Rheumatol"},{"key":"R77-2-20210211","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/rheumatology\/ken107","article-title":"Autonomic nervous symptoms in primary Sj\u00f6gren's syndrome.","volume":"47","author":"Mandl","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"R78-2-20210211","first-page":"1869","article-title":"Autonomic and orthostatic dysfunction in primary Sj\u00f6gren's syndrome.","volume":"34","author":"Mandl","year":"2007","journal-title":"J Rheumatol"},{"key":"R79-2-20210211","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/ard.61.3.232","article-title":"Spectral analysis of heart rate and blood pressure variability in primary Sj\u00f6gren's syndrome.","volume":"61","author":"Barendregt","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"R80-2-20210211","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/ard.62.8.702","article-title":"Parasympathetic nervous system dysfunction in primary Sj\u00f6gren's syndrome.","volume":"62","author":"Hocevar","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"R81-2-20210211","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1046\/j.1365-2249.1996.42748.x","article-title":"Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sj\u00f6gren's syndrome.","volume":"104","author":"Bacman","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"R82-2-20210211","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1076\/ceyr.17.12.1135.5124","article-title":"Human primary Sj\u00f6gren's syndrome autoantibodies as mediators of nitric oxide release coupled to lacrimal gland muscarinic acetylcholine receptors.","volume":"17","author":"Bacman","year":"1998","journal-title":"Curr Eye Res"},{"key":"R83-2-20210211","first-page":"321","article-title":"Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjogren syndrome.","volume":"42","author":"Bacman","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R84-2-20210211","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1002\/art.20625","article-title":"Passive transfer of Sj\u00f6gren's syndrome igG produces the pathophysiology of overactive bladder.","volume":"50","author":"Wang","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R85-2-20210211","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1002\/1529-0131(200010)43:10<2297::AID-ANR18>3.0.CO;2-X","article-title":"Evidence for antimuscarinic acetylcholine receptor antibody-mediated secretory dysfunction in NOD mice.","volume":"43","author":"Nguyen","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R86-2-20210211","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000212370","article-title":"Autoimmune autonomic ganglionopathy.","volume":"26","author":"Winston","year":"2009","journal-title":"Front Neurol Neurosci"},{"key":"R87-2-20210211","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/jnnp.2008.169375","article-title":"Evaluation and treatment of inflammatory myopathies.","volume":"80","author":"Amato","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R88-2-20210211","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.amjmed.2009.02.029","article-title":"Vitamin D: bone and beyond, rationale and recommendations for supplementation.","volume":"122","author":"Stechschulte","year":"2009","journal-title":"Am J Med"}],"container-title":["The Neurologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00127893-201009000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:39:37Z","timestamp":1786041577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00127893-201009000-00002"}},"subtitle":["Clinical Patterns, Diagnostic Paradigms, Etiopathogenesis, and Therapeutic Strategies"],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":87,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/nrl.0b013e3181ebe59f","relation":{},"ISSN":["1074-7931"],"issn-type":[{"value":"1074-7931","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}